MINAPHARM Pharmaceuticals (EGX: MIPH)
Egypt
· Delayed Price · Currency is EGP 156.92
0.00 (0.00%)
At close: Oct 9, 2024
MINAPHARM Pharmaceuticals Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 3,916 | 3,892 | 3,621 | 3,005 | 2,361 | 2,051 | Upgrade
|
| Revenue Growth (YoY) | -2.18% | 7.50% | 20.47% | 27.29% | 15.11% | 6.89% | Upgrade
|
| Cost of Revenue | 2,910 | 2,640 | 2,124 | 1,820 | 1,457 | 1,405 | Upgrade
|
| Gross Profit | 1,007 | 1,252 | 1,496 | 1,185 | 904.48 | 646.1 | Upgrade
|
| Selling, General & Admin | 701.04 | 718.51 | 474.95 | 392.79 | 326.6 | 310.92 | Upgrade
|
| Research & Development | 156.26 | 151.27 | 59.35 | 45.84 | 39.08 | 39.5 | Upgrade
|
| Operating Expenses | 857.43 | 876.91 | 531.63 | 431.37 | 365.68 | 350.42 | Upgrade
|
| Operating Income | 149.12 | 374.66 | 964.74 | 753.96 | 538.8 | 295.68 | Upgrade
|
| Interest Expense | -416.42 | -254.46 | -62.17 | -48.84 | -69.3 | -96.42 | Upgrade
|
| Interest & Investment Income | 27.65 | 14.06 | 9.55 | 5.08 | 5.8 | 8.13 | Upgrade
|
| Currency Exchange Gain (Loss) | -15.2 | -37.3 | 37.52 | -1.76 | 1.64 | -24.5 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.02 | -63.76 | -69.3 | -40.66 | -45 | 25.18 | Upgrade
|
| EBT Excluding Unusual Items | -259.87 | 33.2 | 880.34 | 667.79 | 431.95 | 208.07 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.34 | -0.17 | - | 0.46 | - | 0 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -0.14 | Upgrade
|
| Pretax Income | -260.21 | 33.03 | 880.34 | 668.25 | 431.95 | 207.93 | Upgrade
|
| Income Tax Expense | -45.42 | 10.67 | 249.44 | 193.38 | 121.27 | 59.52 | Upgrade
|
| Earnings From Continuing Operations | -214.78 | 22.36 | 630.89 | 474.87 | 310.68 | 148.41 | Upgrade
|
| Minority Interest in Earnings | -46.38 | -54.35 | -18.23 | -8.46 | -9.9 | -7.32 | Upgrade
|
| Net Income | -261.16 | -31.99 | 612.66 | 466.41 | 300.78 | 141.09 | Upgrade
|
| Preferred Dividends & Other Adjustments | 12.03 | 23.4 | 22.75 | 18.7 | 15.53 | - | Upgrade
|
| Net Income to Common | -273.19 | -55.39 | 589.91 | 447.71 | 285.25 | 141.09 | Upgrade
|
| Net Income Growth | - | - | 31.36% | 55.07% | 113.18% | 21.21% | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 12 | 12 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 12 | 12 | 12 | Upgrade
|
| Shares Change (YoY) | - | -3.57% | -6.67% | - | - | - | Upgrade
|
| EPS (Basic) | -24.69 | -5.01 | 51.41 | 36.42 | 23.20 | 11.48 | Upgrade
|
| EPS (Diluted) | -24.69 | -5.01 | 51.41 | 36.42 | 23.20 | 11.48 | Upgrade
|
| EPS Growth | - | - | 41.17% | 56.95% | 102.17% | 21.21% | Upgrade
|
| Free Cash Flow | -687.03 | -1,292 | -598.45 | -180.6 | 286.84 | -38.35 | Upgrade
|
| Free Cash Flow Per Share | -62.10 | -116.81 | -52.16 | -14.69 | 23.33 | -3.12 | Upgrade
|
| Dividend Per Share | 1.650 | 1.650 | 2.800 | 2.922 | 2.700 | - | Upgrade
|
| Dividend Growth | -41.07% | -41.07% | -4.17% | 8.22% | - | - | Upgrade
|
| Gross Margin | 25.70% | 32.16% | 41.33% | 39.44% | 38.31% | 31.50% | Upgrade
|
| Operating Margin | 3.81% | 9.63% | 26.65% | 25.09% | 22.82% | 14.42% | Upgrade
|
| Profit Margin | -6.98% | -1.42% | 16.29% | 14.90% | 12.08% | 6.88% | Upgrade
|
| Free Cash Flow Margin | -17.54% | -33.21% | -16.53% | -6.01% | 12.15% | -1.87% | Upgrade
|
| EBITDA | 343.18 | 536.04 | 1,086 | 835.91 | 621.7 | 360.61 | Upgrade
|
| EBITDA Margin | 8.76% | 13.77% | 29.99% | 27.81% | 26.33% | 17.58% | Upgrade
|
| D&A For EBITDA | 194.07 | 161.38 | 121.14 | 81.95 | 82.9 | 64.92 | Upgrade
|
| EBIT | 149.12 | 374.66 | 964.74 | 753.96 | 538.8 | 295.68 | Upgrade
|
| EBIT Margin | 3.81% | 9.63% | 26.65% | 25.09% | 22.82% | 14.42% | Upgrade
|
| Effective Tax Rate | - | 32.29% | 28.34% | 28.94% | 28.07% | 28.62% | Upgrade
|
| Advertising Expenses | - | 14.12 | 8.4 | 15.38 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.